PDS Biotechnology (PDSB) Change in Accured Expenses (2014 - 2025)
PDS Biotechnology (PDSB) posted Change in Accured Expenses of -$1.34 million for Q4 2025, compared with -$1.64 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Change in Accured Expenses (2014 - 2025) Analysis & Trends
For FY2025, PDS Biotechnology's Change in Accured Expenses came in at -$2.1 million.
- In prior years, PDS Biotechnology's Change in Accured Expenses was $416,522 in FY2024, -$5.89 million in FY2023, $6.13 million in FY2022 and $452,382 in FY2021 (-29.1%).
- Quarterly Change in Accured Expenses has run from a low of -$6.46 million in Q1 2023 to a high of $5.89 million in Q4 2022 over five years.
- The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q3 2024, with growth of 610.5%; the weakest was Q2 2024, with a decline of 84.6%.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was $622,306 (Q3 2025), -$1.31 million (Q2 2025) and -$66,872 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | 622,306.00 |
| Jun 30, 2025 | -1.31 Mn |
| Mar 31, 2025 | -66,872.00 |
| Dec 31, 2024 | -1.64 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 233,110.00 |
| Mar 31, 2024 | -710,581.00 |
| Dec 31, 2023 | -1.31 Mn |
| Sep 30, 2023 | 356,402.00 |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | -6.46 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 125,582.00 |
| Jun 30, 2022 | 341,453.00 |
| Mar 31, 2022 | -226,236.00 |
| Dec 31, 2021 | 263,858.00 |
| Sep 30, 2021 | 454,054.00 |
| Jun 30, 2021 | -385,003.00 |
| Mar 31, 2021 | 119,473.00 |
API Access
PDS Biotechnology Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();